N. Hirano

Rationale and design of the BRAVERY study (EPOC1701): a multicentre phase II study of eribulin in patients with BRAF V600E mutant metastatic colorectal cancer

S. Nomura, A. Sato, A. Ohtsu, 2019, ESMO Open.

A multicenter phase II study of TAS-114 in combination with S-1 in patients with pretreated advanced gastric cancer (EPOC1604)

S. Nomura, A. Sato, D. Takahari, 2020, Gastric Cancer.

Regorafenib Plus Nivolumab in Patients With Advanced Gastric or Colorectal Cancer: An Open-Label, Dose-Escalation, and Dose-Expansion Phase Ib Trial (REGONIVO, EPOC1603).

S. Nomura, A. Sato, T. Kuwata, 2020, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Multicenter phase I/II trial of BBI608 and pembrolizumab combination in patients with metastatic colorectal cancer (SCOOP Study): EPOC1503.

S. Nomura, A. Sato, A. Ohtsu, 2018 .

Mitigation of paclitaxel-induced peripheral neuropathy in breast cancer patients using limb-cooling apparatus: a study protocol for a randomized controlled trial

F. Hara, T. Mukohara, T. Takano, 2023, Frontiers in oncology.